Literature DB >> 31494452

Military veterans' overdose risk behavior: Demographic and biopsychosocial influences.

Alex S Bennett1, J Alexander Watford2, Luther Elliott3, Brett Wolfson-Stofko3, Honoria Guarino3.   

Abstract

BACKGROUND: U.S. military veterans face many biopsychosocial (BPS) challenges post-service that may elevate risk for opioid-related overdose including physical pain, mental health concerns and social stressors. Some veterans use opioids to manage pain and cope with social readjustment. This study assessed associations between BPS factors and recent engagement in overdose risk behavior in a community sample of post-9/11 veterans who used opioids in New York City.
METHODS: Participants (n = 218) were recruited through convenience sampling and completed a baseline assessment including a validated Opioid Risk Behavior Scale (ORBS) that measured past-30-day engagement in 22 opioid-related overdose risk behaviors. Analyses examined associations between ORBS scores and hypothesized demographic, biological/physical, psychological and social predictors. Incident rate ratios estimated the expected relative difference in ORBS score associated with each predictor.
RESULTS: Participants reported an average of 4.72 overdose risk behaviors in the past 30 days. Significant independent predictors of higher ORBS score, after adjustment for demographics and current prescription medications, were past-30-day: depression symptoms; unsheltered or living in a homeless shelter (vs. private housing); history of mental health treatment; experiencing stressful life events; average pain severity; and pain interference.
CONCLUSION: Veterans face myriad BPS challenges and, while drug-related overdose risks are well understood, findings suggest that other factors-including mental health, pain and stressful life events-may also be associated with overdose risk among opioid-using veterans. The larger challenges veterans face should be considered in the context of BPS forms of pain management when tailoring and delivering overdose prevention interventions.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biopsychosocial framework; Opioid misuse; Opioids; Overdose; US military veterans

Mesh:

Substances:

Year:  2019        PMID: 31494452      PMCID: PMC6791780          DOI: 10.1016/j.addbeh.2019.106036

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  53 in total

1.  Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-2010.

Authors:  Eric J Hawkins; Carol A Malte; Zac E Imel; Andrew J Saxon; Daniel R Kivlahan
Journal:  Drug Alcohol Depend       Date:  2012-02-02       Impact factor: 4.492

2.  Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.

Authors:  Alicia Grattan; Mark D Sullivan; Kathleen W Saunders; Cynthia I Campbell; Michael R Von Korff
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

3.  A Needs Assessment of New York State Veterans: Final Report to the New York State Health Foundation.

Authors:  Terry L Schell; Terri Tanielian; Carrie M Farmer; Lisa H Jaycox; Grant N Marshall; Terry L Schell; Terri Tanielian; Christine Anne Vaughan; Glenda Wrenn
Journal:  Rand Health Q       Date:  2011-03-01

4.  Non-medical use of prescription opioids is associated with heroin initiation among US veterans.

Authors:  Xiulu Ruan; Jin Jun Luo; Adam Marc Kaye; Alan David Kaye
Journal:  Addiction       Date:  2017-01-25       Impact factor: 6.526

5.  Chronic pain prevalence and analgesic prescribing in a general medical population.

Authors:  J David Clark
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

6.  Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.

Authors:  Rose A Rudd; Noah Aleshire; Jon E Zibbell; R Matthew Gladden
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-01-01       Impact factor: 17.586

7.  Accidental poisoning mortality among patients in the Department of Veterans Affairs Health System.

Authors:  Amy S B Bohnert; Mark A Ilgen; Sandro Galea; John F McCarthy; Frederic C Blow
Journal:  Med Care       Date:  2011-04       Impact factor: 2.983

8.  Drugs, detention, and death: a study of the mortality of recently released prisoners.

Authors:  Clarissa S Krinsky; Sarah L Lathrop; Pamela Brown; Kurt B Nolte
Journal:  Am J Forensic Med Pathol       Date:  2009-03       Impact factor: 0.921

9.  Opioid and other substance misuse, overdose risk, and the potential for prevention among a sample of OEF/OIF veterans in New York City.

Authors:  Alex S Bennett; Luther Elliott; Andrew Golub
Journal:  Subst Use Misuse       Date:  2013-07       Impact factor: 2.164

10.  Trends in long-term opioid therapy for noncancer pain among persons with a history of depression.

Authors:  Jennifer Brennan Braden; Mark D Sullivan; G Thomas Ray; Kathleen Saunders; Joseph Merrill; Michael J Silverberg; Carolyn M Rutter; Constance Weisner; Caleb Banta-Green; Cynthia Campbell; Michael Von Korff
Journal:  Gen Hosp Psychiatry       Date:  2009-08-27       Impact factor: 3.238

View more
  3 in total

1.  Between- and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference.

Authors:  Charles M Cleland; Alex S Bennett; Luther Elliott; Andrew Rosenblum; Peter C Britton; Brett Wolfson-Stofko
Journal:  Drug Alcohol Depend       Date:  2019-11-14       Impact factor: 4.492

2.  Validation of the Opioid Overdose Risk Behavior Scale, version 2 (ORBS-2).

Authors:  Luther Elliott; Dev Crasta; Maria Khan; Alexis Roth; Traci Green; Andrew Kolodny; Alex S Bennett
Journal:  Drug Alcohol Depend       Date:  2021-04-20       Impact factor: 4.852

3.  Understanding Adoption and Preliminary Effectiveness of a Mobile App for Chronic Pain Management Among US Military Veterans: Pre-Post Mixed Methods Evaluation.

Authors:  Timothy P Hogan; Bella Etingen; Nicholas McMahon; Felicia R Bixler; Linda Am; Rachel E Wacks; Stephanie L Shimada; Erin D Reilly; Kathleen L Frisbee; Bridget M Smith
Journal:  JMIR Form Res       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.